Gastrointestinal Cancer News

Breast cancer survivors who harbor BRCA gene mutation are at elevated risk for second primary cancers, according to study results.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.

Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, with researchers suggesting the recommended 10-year rescreening interval may be extended for this population.

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and clinical data and may be leveraged to increase screening in at-risk populations.

Improvement in adenoma detection rate among physicians with a baseline rate of less than 26% was significantly associated with decreased patient risk for colorectal cancer, according to results of an observational study conducted in Poland.

Although most older adults supported guidelines to discontinue colon cancer screening after age 75 years, a “sizable minority” did not, regardless of estimated life expectancy, according to a study published in JAMA Network Open.

U.S. Surgeon General Vivek Murthy, MD, MBA, issued an advisory today that includes several recommendations designed to reduce the impact of alcohol on cancer incidence and mortality.

Satricabtagene autoleucel improved PFS compared with physician’s choice of therapy for patients with Claudin18.2 expression-positive advanced gastric or gastroesophageal junction cancers, according to the agent’s manufacturer.